Lee et al. reported that downregulation of SFTPB expression increased the migration of NSCLC cells, while ectopic expression of SFTPB inhibited tumor growth and EMT in an NSCLC xenograft model [21]. The gene discussed is SFTPB; the disease is non-small cell lung carcinoma.